BOK (BCL-2-related ovarian killer) is a member of the proapoptotic BCL-2 family that is highly expressed in the human placenta. BOK excess causes increased trophoblast autophagy and apoptosis in pre-eclampsia, a pathological condition of hypoxia and oxidative stress. In the present study, we identified an HRE (hypoxia-response element) at the junction of exon-1 and intron-1 ( + 229 to + 279) in the human BOK gene, as well as an antisense transcript driven by a promoter located in intron-2. The isolated BOK-HRE bound hypoxia-inducible HIF (hypoxiainducible factor) proteins in vitro as well as in trophoblastic JEG3 cells and was functional in its natural position as well as in front of a heterologous promoter. Being a reverted repeat, the BOK-HRE functioned in both orientations. This directionless feature of the BOK-HRE facilitates hypoxia regulation via HIF of both BOK and its antisense transcript as demonstrated by RNAi knockdown of the HIF system. Although the antisense transcript was expressed in several human carcinoma cell lines, including choriocarcinoma-derived JEG3 cells, no antisenseregulated mechanism for BOK expression was noted. Taken together, these findings indicate that hypoxia-induced expression of BOK in placental cells is regulated via HIF and is not affected by its antisense transcript.
INTRODUCTION
BOK (BCL-2-related ovarian killer) belongs to the multidomain pore-forming subfamily of pro-apoptotic BCL-2 family members [1] [2] [3] . BOK is highly expressed in reproductive tissues, including placenta [1] [2] [3] [4] . Three BOK splice isoforms have been characterized: BOK-L, BOK-S and BOK-P [3] . All three BOK isoforms are pro-apoptotic proteins, but only BOK-L is antagonized by an anti-apoptotic BCL-2 family member, namely MCL1 (myeloid cell leukaemia factor 1) [5] . Oxygen is an important regulator of cell death [6, 7] . Hypoxia can induce apoptosis via the intrinsic pathway as a result of an imbalance between pro-apoptotic (BAX, BOK and BAK) and prosurvival (MCL1, BCL-2 and BCL-2L1) members of the BCL-2 protein family [8, 9] . Pre-eclampsia, a disorder of pregnancy, is characterized by increased trophoblast cell death and placental hypoxia [10] [11] [12] . Hypoxia has been shown to increase the expression of pro-apoptotic BAX and to decrease the expression of pro-survival BCL-2 in human trophoblast cells [13] [14] [15] . However, expression of BCL-2, BAX and BAK is unchanged in placentae of pregnancies complicated by pre-eclampsia [16, 17] . In contrast, BOK is overexpressed in placental tissues at 5-8 weeks of gestation, when placental pO 2 is low [11] , and in early-onset severe pre-eclamptic placentae [3] . In addition, hypoxia/oxidative stress increases BOK levels in placental explants and cells [3, 18] . Thus, although hypoxia controls the expression of various BCL-2 proteins, only BOK and MCL1 have so far been implicated in increased trophoblast autophagy and apoptosis in pre-eclampsia [3, 4, 18] .
The hypoxia response is mediated via the HIF (hypoxiainducible factor) family of transcriptional regulators. HIF functions by binding to HREs (hypoxia-response elements) containing the consensus sequence 5 -RCGTG-3 of various target genes and activating the transcription of these genes. HIF consists of a heterodimer of α-and β-subunits. HIF-1β, also known as the ARNT (aryl hydrocarbon nuclear translocator) [19] , is widely and constitutively expressed and is not regulated by hypoxia [20] . In mammals, at least two α-subunits of HIF, HIF-1α and HIF-2α, have been identified [21] [22] [23] . The regulation of α-subunits occurs at the level of protein degradation. During normoxia, α-subunits undergo rapid degradation. This degradation is mediated by prolyl hydroxylases, a family of dioxygenase enzymes that catalyse hydroxylation of conserved proline residues in the critical ODD (oxygen-dependent degradation domain). Hydroxylated HIF α-subunits are recognized by the von Hippel-Lindau E3 ubiquitin ligase complex and are targeted for proteosomal degradation. Under hypoxic conditions, proline hydroxylation is inhibited, allowing the α-subunits to accumulate and to migrate to the nucleus, where, upon binding to the β-subunit, the HIF complex interacts with HREs in transcriptional regulatory regions of multiple target genes. Recent studies have demonstrated that the expression of some pro-apoptotic (NIX and NIP3) and prosurvival (MCL-1) BCL-2 family members is directly regulated by HIF under conditions of reduced oxygenation [7, 24, 25] .
In order to investigate whether increased BOK expression in placental hypoxia/oxidative stress [3, 18] is regulated by HIFs, we analysed the genomic sequence of the human BOK gene (GenBank ® accession number NG029488). Several putative HREs are present in the human BOK promoter region, including a sequence cluster located at the junction of exon-1 and intron-1 showing an inverted repeat with perfect homology with the consensus HRE sequence. Also, an antisense transcript was found (GenBank ® accession numbers AL534911 and BU184197) starting from exon-2 and ending at the BOK upperstream promoter region, suggesting a potential antisense regulation of BOK expression. In the present study we have characterized both the antisense promoter and HRE. We observed that the BOK-HRE was functional in both orientations and that BOK is an HIF target gene. The antisense transcript was expressed in several carcinoma cell lines, including choriocarcinoma JEG3 cells, although no regulatory role in BOK expression was identified.
MATERIALS AND METHODS

Nuclear protein extracts
Human choriocarcinoma JEG3 cells were maintained in monolayer culture in DMEM (Dulbecco's modified Eagle's medium) supplemented with 10 % FBS. Nuclear extracts were prepared essentially as described previously [26] . Cells (10 7 ) exposed to either 21 % oxygen (controls) or 2 % oxygen for 6 h were collected, washed in PBS and resuspended in 0.8 ml of icecold low-salt buffer A [10 mM Hepes/KOH (pH 7.9), 1.5 mM MgCl 2, 10 mM KCl, 0.5 mM DTT, 0.2 mM PMSF and a protease inhibitor mixture (Roche)]. After 10 min on ice, the nuclei were collected by centrifugation (11 000 g for 2 min at 4
• C) and the pellet was resuspended in high-salt buffer B [20 mM Hepes/KOH (pH 7.9), 20 % glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 0.2 mM PMSF and proteinase inhibitors]. Nuclei were incubated on ice for 30 min and centrifuged at 11 000 g for 5 min at 4
• C to remove cell debris. The protein concentration of the nuclear extract was determined and small aliquots were frozen at − 80
• C.
EMSA
Double-stranded oligonucleotides with 5 -overhangs were generated and labelled by incorporating [α-32 P]dCTP with Klenow enzyme. Labelled probes (20 000 c.p.m.) were added to a 20 μl binding reaction mixture containing 10 μl of 2× binding buffer [20 mM Hepes/KOH (pH 7.9), 20 % glycerol, 1 mM CaCl 2 , 10 mM MgCl 2 , 0.2 mM EDTA and 1 mM DTT], 0.8 μg of poly(dI/dC) and 60 mM KCl and then incubated with nuclear extracts (8 μg) for 15 min at room temperature. Competition assays were performed by adding a 10, 50 or 100 molar excess of unlabelled oligonucleotides to the binding reaction. In supershift experiments, anti-HIF-1α antibodies (Santa Cruz Biotechnology) were added to the binding reaction for an additional incubation of 30 min. The protein-DNA complexes were separated from the free probes by electrophoresis in a 6 % polyacrylamide gel of a low ionic strength [0.5×TBE (50 mM Tris/borate, 50 mM boric acid and 1 mM EDTA)] and dried gels were exposed for autoradiography. The oligonucleotides used in the EMSA were as follows (HRE core-binding site underlined): BOKwt, 5 -GC-GCGGCGGGCGTGGCGTCCGTGCCGGGGTGCCCGGGG-TGCCACGGGAACGGCGAGGGCCGGGGACACGCGCGC-AGGACGCCAG-3 ; and BOKmt, 5 -GCGCGGCGGGAAAG-GCGTCCGTGCCGGGGTGCCCGGGGTGCCACGGGAACG-GCGAGGCCGGGGACTTTCGCGCAGGACGCCAG-3 .
ChIP assay
The ChIP assay was performed as described in [27] with minor modification. JEG3 cells were cross-linked at 37
• C for 10 min in 1 % formaldehyde. Cells were then collected, nuclei were isolated by incubation of the cells first in cell lysis buffer [10 mM Tris/HCl, 10 mM NaCl and 0.2 % Nonidet P40 (pH 8.0)] containing protease inhibitors and PMSF for 10 min on ice and then lysed in ice-cold nuclei lysis buffer [50 mM Tris/HCl, 10 mM EDTA, 1 % SDS, 10 mM sodium butyrate, protease inhibitors and 50 μg/ml PMSF (pH 8.1)]. Chromatin was broken into relatively small fragments by sonicating the lysate under conditions in which the fragments have an average size of 500-1000 bp. Sonication was done on ice with 6-8 pulses of 15 s at 80 % of maximum power using a Misonix Sonicator 3000 equipped with a microtip. Samples were precleared with Protein G-coated agarose beads (Santa Cruz Biotechnology) in immunoprecipitation wash buffer 1 [20 mM Tris/HCl, 50 mM NaCl, 2 mM EDTA, 0.1 % SDS and 1 % Triton X-100 (pH 8.1)]. The pre-cleared supernatants were aliquoted for subsequent immunoprecipitation. Equal aliquots of pre-cleared chromatin samples were incubated overnight with rabbit anti-HIF-1α (Santa Cruz Biotechnology), rabbit anti-HIF-2α (Santa Cruz Biotechnology) or rabbit anti-HIF-1β (Santa Cruz Biotechnology) antibodies or non-specific rabbit antiserum at 4
• C. An additional aliquot of chromatin sample, 2 % of the volume of other aliquots (input), was saved for the subsequent PCR analysis. Immune complexes were collected by incubation with 50 μl of Protein G plus agarose beads for 2 h at 4
• C. The pellets were washed twice with 500 μl of immunoprecipitation wash buffer 1 and twice with immunoprecipitation wash buffer 2 [10 mM Tris/HCl, 0.25 M LiCl, 1 mM EDTA, 1 % Nonidet P40 and 1 % deoxycholate (pH 8.1)]. Immune complexes were eluted from the beads by incubation twice under agitation at 37
• C with 150 μl of immunoprecipitation elution buffer (0.1 M NaHCO 3 and 1 % SDS). RNase A (3 μg/ml) and NaCl (0.3 M) were added to the pooled eluants and cross-linking was reversed by incubation for 4-5 h at 65
• C. Samples were digested with proteinase K (0.2 mg/ml) for 1-2 h at 45
• C. Immunoprecipitated DNA was purified by extraction with phenol/chloroform followed by ethanol precipitation. Purified immunoprecipitated DNA and input DNA were resuspended in 50 and 100 μl of water respectively. DNA (3 μl) was amplified by PCR with a temperature cycle of 30 s at 94
• C, 30 s at 65
• C, and 25 s at 72
• C for 35 cycles. The following primer pairs were used: 5 -primer, 5 -GCCCCCAGGGTTGCCTTTCCCTTAGAAG-3 and 3 -primer, 5 -GCCGCCCACCTCCGCCGCTGGCGTCCTG-3 for the human BOK promoter region containing the HRE ( − 130/ + 280 relative to the transcription start site); 5 -primer, 5 -GCTGGCGGGTAGGTTTGAATCATCAC-3 and 3 -primer, 5 -CCTCATCTGGCCTGCAGACATCAAAGTG-3 for the human VEGF (vascular endothelial growth factor) HRE region (positive control); and 5 -primer, 5 -GCCGCCGAGATCATGGACGCCTTTGAC-3 and 3 -primer, 5 -GCCTTGGCCTGGGCCACCAGCTCCTTGTCTG-3 for the human BOK exon-2 region where there is no HRE (negative control).
Plasmid construction
Expression vectors
The human HIF-1α and HIF-2α (HIF1A and HIF2A respectively) cDNAs were reverse-transcribed from total RNA isolated from the human JEG3 cell line under hypoxic conditions. The cDNAs were then PCR-amplified to generate only the coding regions, with primers containing the KpnI and NotI restriction sites at the 5 -and 3 -ends respectively. The purified PCR products were digested with KpnI and NotI and ligated into the pcDNA3.1 plasmid digested with the same restriction enzymes. All constructs were verified by sequencing.
Reporter constructs SEAP2 (secreted alkaline phosphatase) constructs containing various lengths of human BOK promoter were generated by PCR amplification from a 2.4 kb ( − 508/ + 1912 bp) XbaI/HindIII BOK genomic template and insertion into a SEAP2 reporter plasmid (pSEAP2-Basic, Clontech). The following primers were used for amplification of the BOK-HRE (1 kb) construct (restriction sites underlined): 5 -primer, 5 -AAGCTTCTAAAAGGAAATACAGGAGGATATC-3 and 3 primer, 5 -GCGCCACCTTCTTTCAGAGCCCGAATTCAG-3 . The same 5 -primer but a different 3 -primer (5 -GCCG-GGCTCGAGTTCTGGCTTCAGGATCTGCTC-3 ) was used to remove the HRE sequence. The purified PCR products were digested with XhoI and HindIII and ligated into the pSEAP2-Basic plasmid digested with the same restriction enzymes. The anti-sense promoter of human BOK was generated by PCR amplification from the 2.4 kb XbaI/HindIII genomic template by using the following PCR primers (restriction sites underlined): 5 -primer, 5 -GCGGCCGGTACCGTCGACT-CTAGATCCTTCTGAACTTCTC-3 and 3 -primer, 5 -GCGTC-GGCCTCGAGCAGATCCTGAAGCCAGAACTC-3 . The purified PCR products were digested with KpnI and XhoI, and ligated into the pSEAP2-Basic plasmid digested with the same restriction enzymes. To generate constructs with a heterologous promoter, synthesized human BOK-HRE wt (wt is wild-type; HRE site underlined) (GCGCGGCGGGCGTGGCGTCCG-TGCCGGGGTGCCCGGGGTGCCACGGGAACGGCGAGG-CCGGGGACACGCGCGCAGGACGCCAG), BOK-HRE mt (mt is mutant) (GCGCGGCGGGAAAGGCGTCCGTGCCGGG-GTGCCCGGGGTGCCACGGGAACGGCGAGGCCGGGGA-CTTTCGCGCAGGACGCCAG), and two copies of EPO-HRE (EPO is erythropoietin) (GCGCGGTACCGTCGACGCCTA-CGTGCTGTCTCACACAGCCTGTCTGACGCCTACGTGCT-GTCTCACACAGCCTGTCTCGAGCGCGC) in tandem were cloned into the KpnI/XhoI restriction site of the pSEAP2-Promoter (Clontech) containing the SV40 promoter.
Transient transfection and SEAP2 assay
HEK (human embryonic kidney)-293T cells or JEG3 cells were transiently transfected in 24-well culture plates using Lipofectamine TM 2000 (Invitrogen, Life Technologies) with 0.5 μg of pSEAP2 reporter plasmids and 0.02 μg of β-galactosidase plasmid as an internal control for transfection efficiency. In co-transfection experiments, cells were cotransfected with pcDNA3.1 empty vector, pcDNA-HIF1α or pcDNA-HIF2α expression plasmids. The total amount of DNA transfected in each culture well was made up to 0.5 μg with pcDNA3.1 plasmid DNA. In silencing experiments, cells were co-transfected with Origene ® Trilencer-27 siRNAs (targeting human HIF-1α, HIF-1β, HIF-2α or a scrambled sequence as a negative control). At 6-12 h after transfection, the cultured medium was removed and fresh growth medium added. Cells were incubated for another 24 h before 50 μl of culture supernatant was collected. Cell debris was removed by centrifugation (11 000 g for 5 min at 22
• C) and SEAP2 activities were measured using the Phospho-Light TM reagent as outlined by the manufacturer (Tropix, Applied Biosystems, Life Technologies). Light intensity was measured in an EG&G Berthold luminometer. All transfections were performed in triplicate and repeated at least four times.
Real-time PCR
Cell cultures were washed with PBS and RNA was extracted with TRIzol ® and reverse-transcribed using random hexamers or poly(dT) (Invitrogen). Real-time PCR was carried out as described previously [28] using primers for the human BOK gene (Supplementary Table S1 at http://www.biochemj.org/bj/461/bj4610391add.htm).
Western blot analysis
Whole-cell extracts were prepared by harvesting cells in RIPA buffer followed by sonication. Equivalent amounts of nuclear and/or whole-cell proteins were separated by SDS/PAGE (8 % gel) under reducing conditions. After transfer on to PVDF membrane, proteins were revealed with and anti-BOK antibody using enhanced chemiluminescence (GE Healthcare). The anti-rabbit BOK antibody (1:500 dilution) was from Abgent. Horseradish peroxidase-conjugated IgG was used as a secondary antibody (1:10000 dilution; Jackson ImmunoResearch).
miRNA detection
Short RNAs were isolated from HepG2 or JEG3 cells cultured at 2 % or 21 % oxygen using the mirPremier microRNA Isolation Kit according to the manufacturer's instructions (Sigma). Poly(A) tails were then added to the short RNAs by poly(A) polymerase (Invitrogen) before reverse transcription. A 3 adaptor to the cDNAs was added by terminal deoxynucleotidyl transferase (Invitrogen) using dCTP as a substrate. The cDNAs obtained were then used as a template for PCR with 5 and 3 adaptors as primers: 5 -GATTACGC-CAAGCTATTTAGGTGACACTATAGTTTTTTTTTTTTTTT-3 and 5 -GGCCAGTGAATTGTAATACGACTCACTATAGGG-GGGGGGGGGG-3 . Amplified products were separated on an agarose gel, transferred on to nitrocellulose membrane and hybridized with a DIG (digoxigenin)-labelled probe (Roche Diagnostics) corresponding to the antisense-BOK sequence.
Antisense regulatory RNA assays HEK-293T cells were transfected with empty pcDNA3.1, pcDNA-BOK-L, pcDNA-antisense (AS)-BOK or pcDNA-BOK-L and pcDNA-antisense-BOK together using Lipofectamine TM 2000 (Invitrogen) as described previously [4] . Cells were harvested 48 h after transfection, lysed and lysates were analysed by immunoblotting with an anti-BOK antibody. For inducible expression we used a tetracycline-inducible HEK-293 T-REx cell system (Invitrogen). T-REx 293 cells were transfected with the various expression vectors (pcDNA5/TO/GFP and pcDNA5/TO/AS-BOK) alone or together. At 24 h after transfection, medium was replaced with medium containing 10 μg/ml doxycycline to induce the expression of target genes. Cells were harvested 24 h after doxycycline treatment and RNA was extracted. RT (reverse transcription)-PCR was performed with specific primers to detect the expression of antisense-BOK and BOK isoforms (Supplementary Table S1 ).
Data analysis
Data are presented as means + − S.D. Statistical significance was determined by one-way ANOVA followed by assessment of differences using Student-Newman-Keuls test. Statistical analysis was performed with the JMP statistical software and significance was accepted at P < 0.05. 
RESULTS
Genomic sequence analysis of the BOK promoter region
The genomic structure of the human BOK gene (GenBank ® accession number NG029488) was scanned for potential HREbinding sites. The BOK gene is composed of five exons and four introns localized on chromosome 2q37.3. Several putative HREs are present in the human BOK promoter region, which are 100 % homologous with the consensus HRE (-A/GCGTG-), including a sequence cluster located at the junction of exon-1 and intron-1, spanning from + 229 to + 279 (numbering relative to the transcription start site of BOK), showing an inverted repeat with perfect homology with the consensus HRE sequence (Figure 1 ). An antisense transcript was found (GenBank ® accession numbers AL534911 and BU184197) starting from exon-2 and ending at the BOK upperstream promoter region with features of miRNA with a loop-stem region close to the transcription start site of BOK. All these features of this region prompted us to isolate and characterize the inverted repeat located + 229 to + 279 of the human BOK gene and to elucidate its functionality as a HRE in vitro and in vivo.
Hypoxia-inducible proteins bind to a putative BOK-HRE
Gel-shift assays were carried out with a double-stranded oligodeoxyribonucleotide probe containing the putative HRE using nuclear extracts from either 21 % (control) or 2 % (hypoxia) O 2 -exposed JEG3 cells (Figure 2) . No specific complex was detected using nuclear extracts from cells cultured at 21 % O 2 ( Figure 2, lane 2) . However, a strong binding activity was observed with nuclear extracts from JEG3 cells exposed to 2 % O 2 for 6 h (Figure 2, lane 3) . Increasing amounts of non-radioactive BOK-HRE probe (Figure 2 , lanes 4-6) efficiently out-competed the hypoxia-induced 32 P-radiolabelled complex formation. In contrast, no competition was observed with excess of nonradioactive BOK-HRE mt oligonucleotide that had been mutated by converting three nucleotides of the HRE core sequence (Figure 2,  lane 7) . When a specific anti-HIF-1α antibody (Figure 2 , lane 8) was added to the binding reaction, the hypoxia-inducible complex (Figure 2, lane 3) was partially supershifted, indicating that HIF-1α was present in this complex. The specificity of the binding reaction was further confirmed by using the BOK-HRE mt oligonucleotide as a radioactive probe with nuclear extracts from 
HIF proteins bind to BOK-HRE in vivo
ChIP assays were performed to detect whether HIF proteins bind to the BOK-HRE in vivo. JEG3 cells cultured for 6 h at either 2 % or 21 % O 2 were fixed with formaldehyde and cell nuclei were isolated and sonicated. The sonicated chromatin lysates were immunoprecipitated with anti-HIF-1α, anti-HIF-2α or anti-HIF-1β antibodies. Extracted DNA was used to amplify a 380 bp fragment of the human BOK intron-1 region. A visible band was only observed in hypoxia-exposed samples immunoprecipitated with anti-HIF-1α ( Figure 3 
BOK-HRE responds to HIF proteins
The synthesized BOK-HRE oligonucleotide (encompassing + 229 to + 279 bp) and its mutated counterpart were cloned upstream of the SV40 promoter driving the SEAP2 reporter gene. In addition, two EPO-HREs in tandem were cloned upstream into the SV40-SEAP2 expression vector (positive control). To test the hypoxia response in the context of a heterologous promoter, HEK-293T and JEG3 cells were transiently transfected with these reporter constructs together with expression vectors encoding HIF-1α or HIF-2α, or empty vector pcDNA3.1 (control). For each construct, the fold increase in SEAP2 activity elicited by co-transfected expression vector was determined relative to control SEAP2 activity from each promoter construct. When placed upstream of the SV40 promoter, the BOK-HRE induced transcriptional activation after co-transfection with either HIF-1α or HIF-2α ( Figures 4B and 4C) . Thus, in the context of a heterologous promoter, the BOK-HRE is able to be activated by both HIFs. Also, we observed that the BOK-HRE functions in both orientations ( Figures 4B and 4C ); in agreement with this BOK-HRE being a reverted repeat.
BOK-HRE functions in the native promoter
Although the isolated BOK-HRE is functional upstream of the SV40 promoter, the question remains whether the BOK-HRE is functional in its native promoter, i.e. does deletion of this BOK-HRE from the promoter abolish the hypoxic response? To test the hypoxia responsiveness of the + 229 to + 279 HRE region in its natural location, we used genomic fragments encompassing this HRE and its native minimal promoter. Two fragments, containing 0.8 and 1.0 kb of the 5 -flanking region of the human BOK promoter and its downstream sequence, were cloned into the SEAP2-Basic expression vector. The 1.0 kb clone ( − 508/ + 509 bp) was used to create a reporter construct containing wild-type BOK-HRE, whereas the 0.8 kb clone ( − 508/ + 219 bp) lacked the 3 -BOK-HRE region and served as a negative control of the 1.0 kb counterpart. The reporter constructs were transfected into HEK-293T or JEG3 cells. For each construct, the fold increase in SEAP2 activity elicited by 2 % O 2 treatment was determined relative to normoxic SEAP2 activity from each promoter construct. For both cell lines tested, the reporter activity increased in the 1.0 kb construct containing the BOK-HRE, whereas the 0.8 kb vector with the BOK-HRE deletion showed no such effect ( Figure 5 ). These results show that the BOK-HRE is a functional HRE in the context of its native promoter acting as a hypoxia-sensitive enhancer.
BOK-HRE functions in the antisense promoter
Since genomic data mining revealed an antisense transcript ( − 248/ + 900 bp) and BOK-HRE functions in both orientations ( Figures 4B and 4C) , we investigated the response of the antisense promoter to hypoxia via the BOK-HRE. A 1.7 kb antisense promoter of human BOK, starting from intron-2 to exon-1, was cloned into the SEAP2-Basic reporter plasmid. The 1.0 kb clone, containing the BOK-HRE and BOK native promoter, was used as a positive control of the 1.7 kb counterpart. Both reporter constructs were transfected into HEK-293T or JEG3 cells. For each construct, the fold increase in SEAP2 activity elicited by 2 % O 2 treatment was determined relative to normoxic activity from each promoter construct. In both cell lines, the reporter activity of the 1.7 kb antisense promoter construct increased upon exposure to low oxygen ( Figure 6 ), although its baseline activity was less than that of the 1.0 kb native promoter. These results suggest that there is a functional antisense promoter in the BOK region, which is weaker than the native promoter. The BOK-HRE appears to serve as a hypoxia-sensitive enhancer for both promoters.
Knockdown of the HIF system suppresses the BOK-HRE response to hypoxia
Since BOK-HRE appears to serve as a hypoxia-sensitive enhancer for the native as well as antisense promoter, further experiments were performed after knockdown of the HIF system using siRNA to determine whether HIF-dependent interactions actually contribute to the expression of BOK under hypoxic conditions. Expression plasmids (pSEAP2-Basic, 0.8 kb BOKpSEAP2 missing the BOK-HRE, 1.0 kb-BOK-SEAP2 and 1.7 kb antisense-BOK-pSEAP2) and Origene ® Trilencer-27 siRNAs targeting human HIF-1α, HIF-2α or HIF-1β (or a negative scrambled sequence control) were introduced into HEK-293T or JEG3 cells. The 0.8 kb BOK-pSEAP2 construct lacking the BOK-HRE region served as a negative control, whereas the 1.0 kb construct, containing the BOK-HRE and native promoter, and the 1.7 kb construct (antisense promoter of human BOK containing BOK-HRE in the opposite orientation) were used to determine the HIF-dependent interactions under hypoxia. For each construct, the fold increase in SEAP2 activity elicited at 2 % O 2 was determined.
As anticipated the reporter activities of the 1.0 kb and 1.7 kb constructs were significantly greater in both cell lines exposed to low oxygen compared with the 0.8 kb construct lacking the BOK-HRE (Figure 7 ). These elevated SEAP2 activities were abolished in the presence of siRNA against human HIF-1α, HIF-2α and HIF-1β, whereas scrambled control siRNA had no such effect. These results suggest that HIF-dependent interactions with the BOK-HRE contribute to the expression of BOK under hypoxic conditions. 
Expression and function of antisense RNA
To confirm the existence of the antisense transcript, an expression vector containing the putative antisense promoter plus the transcipt of human BOK was generated by PCR amplification from a 2.4 kb ( − 508/ + 1912 bp) XbaI/HindIII genomic BOK template. The amplified PCR products were first cloned into a TA-cloning vector followed by subcloning of the fragment of interest into a pcDNA3.1 vector in which the original CMV (cytomegalovirus) promoter was removed, thereby leaving the expression of the antisense transcript under the control of its own promoter. The antisense expression vector was transfected into HEK-293T cells and total RNA was extracted 24 h later. Reverse transcription and PCR were performed using 5 -primer, 5 -GC-CCCCAGGGTTGCCTTTCCCTTAGAAG-3 , and 3 -primer, 5 -GCCTTGGCCTGGGCCACCAGCTCCTTGTCTG-3 . Agarose electrophoresis revealed one specific PCR product of 400 bp in cells transfected with the antisense expression vector; 450 bp shorter than the predicted antisense transcript size. Subsequent sequencing of the 400 bp transcript showed that the antisense RNA was spliced to remove intron-1, similar to its sense BOK counterpart ( Figure 1B) . We then performed RT-PCR using total RNA from human JEG3 cells exposed to 2 % or 21 % oxygen. Independent of oxygen tension, a similar 400 bp PCR product was identified in JEG3 cells as seen in HEK-293T cells transfected with the antisense expression vector ( Figure 8A ).
Subsequent experiments revealed constitutive expression of the antisense transcript in various human epithelial carcinoma (HeLa, HepG2 and JEG3), but not HEK-293T, cell lines, with the highest expression in HepG2 cells ( Figure 8B ). Taken together, the data demonstrate that an active antisense promoter inside intron-2 of the BOK gene controls the expression of an antisense RNA in human JEG3 cells. A previous report has identified an antisense-BOK (BOK-AS1; shares the exon-1 region with our antisense transcript) that potentially could act as a regulatory RNA [29] .
To investigate the overlap of the BOK-AS1 transcript with our antisense RNA we performed RT-PCR starting from exon-2 and ending at the 3 region of BOK-AS1 using the following primers: 5 -GCCTTGGCCTGGGCCACCAGCTCCTTGTCTG-3 , and 5 -TTTTTTTGAGAGAGAAGAGAGACCATATTCAC-3 or 5 -GGATTCAGTACTCTCCGCGATTTCAGGCATC-3 . No PCR products were detected in HepG2 cells, indicating that our antisense RNA is a different transcript than BOK-AS1. Since analysis of the coding frames of the antisense RNA dismissed translation into a peptide, we speculated that it probably serves as a regulatory RNA. The antisense RNA had some features of miRNA with a potential loop-stem structure, specifically in the region close to the transcription start site of BOK. This prompted us to design experiments typically to detect miRNAs. Short RNAs were isolated from HepG2 or JEG3 cells and poly(A) tails were added. The short RNAs were then reversetranscribed followed by the addition of a 3 adaptor to cDNAs. The cDNAs were then amplified by PCR using the 5 and 3 adaptors as primers; amplified products were separated on 3 % agarose gels and transferred on to nitrocellulose membrane, followed by hybridization with a DIG-labelled probe corresponding to the antisense sequence. However, no putative miRNA was detected (results not shown), which led us conclude that the antisense RNA does not function as a regulatory miRNA. In subsequent experiments, we co-transfected BOK and antisense RNA expression vectors into HEK-293T cells to determine whether the antisense transcript would interfere with the translation of BOK. No interference was observed (Supplementary Figure S1A at http://www.biochemj.org/bj/461/bj4610391add.htm). We then explored the possibility of the antisense RNA working via RNA masking; an antisense masks a splice site on the sense premRNA sequence, which prevents a given splice variant from being formed and shifts the balance towards splice variants that do not require splicing of the masked region. To test this possibility, we used T-REx 293 cells (a cell line stably expressing a tetracycline repressor protein), which constitutively express BOK but no antisense-BOK. The cells were transfected with pcDNA/TO/antisense-BOK expression vector and 24 h later the medium was changed to fresh medium containing doxycycline to induce the expression of antisense-BOK. After 24 h of incubation, cells were harvested, and RNA was extracted and analysed by RT-PCR using specific primers to detect the expression of antisense-BOK and BOK isoforms (see Supplementary Table S1 ). Induced expression of antisense-BOK had no apparent effect on the BOK isoform [BOK-L (600 bp), BOK-P (350 bp) and the newly identified BOK-PS (exon-1 directly spliced on to exon-4; 250 bp) (Supplementary Figure S1B) ] expression, hence ruling out RNA splicing interference.
DISCUSSION
Oxygen levels are low in the uterus at the time of implantation in many species [30] . This condition favours optimal pre-implantation and embryo development. Early placental development occurs under similar conditions as it is now recognized that the maternal circulation to the placenta is not fully established until the end of the first trimester [31] . A low oxygen environment benefits early placental development by promoting angiogenesis [32, 33] and cytotrophoblast proliferation [34] . Placental tissues face a major oxidative challenge when the maternal circulation to the placenta is established at the end of the first trimester. Intraplacental oxygen concentrations rise approximately 3-fold at the time that the villous space opens [35, 36] . The placenta has adapted to these physiological variations of oxygen levels. In pre-eclampsia, however, inadequate uteroplacental perfusion as a result of incomplete trophoblast-mediated remodelling of myometrial spiral arteries leads to chronic placental hypoxia and increased trophoblast autophagy and programmed cell death [10, 18, 37] . The exact mechanisms causing this increase in trophoblast autophagy and apoptosis remain unclear, but hypoxia/ischaemia induces alterations in expression of pro-and anti-apoptotic BCL-2 proteins [8] , thereby affecting the intricate balance between factors that induce or counteract cell death. Previously, we reported that cell death-inducing BOK is overexpressed in healthy placental explants under hypoxia and in pre-eclamptic placentae [4, 18] . Additionaly, we showed that this increase in BOK leads to increased trophopblast autophagy [18] and apoptosis [4] . In the present study, we demonstrate that hypoxic induction of BOK transcription is dependent on HIF. In silico analysis of the human BOK promoter revealed an inverted repeat with perfect homology with the consensus HRE sequence at the junction of exon-1 and intron-1 ( + 229 to + 279). We demonstrated by gel-shift and ChIP assays that this BOK-HRE binds HIF proteins in vitro as well as in vivo. Reporter gene analyses showed the functionality of the BOK-HRE in its natural position as well as in front of a heterologous promoter. HIF-knockdown experiments using siRNA demonstrated that HIF-dependent interactions with the BOK-HRE contribute to the expression of BOK under hypoxic conditions. These findings indicate that the consensus HRE repeat located in intron-1 of the BOK gene is a functional HRE that acts as a hypoxia-sensitive enhancer.
Several other genes encoding pro-apoptotic BCL-2 proteins have been identified to be HIF-1 targets, including NIX and NIP3 [24, 25] . Hypoxia down-regulates pro-apoptotic BID via HIF-1 in colon cancer cells [38] , but down-regulation of proapoptotic BAD by hypoxia in these cells was independent of HIF-1. Both BID and BAD are down-regulated by hypoxia in the human choriocarcinoma cell line JAR [39] . Whether the decrease in BID and BAD expression in these trophoblastic cells occurs via either a HIF-dependent or -independent mechanism is unknown. Pro-survival MCL1 which partners with BOK is also a HIF target [7, 40] . Hypoxic up-regulation of both BOK and MCL1 via HIF in the placenta suggest that their intricate balance is maintained. Unfortunately, placental hypoxia triggers a caspasemediated cleavage of the anti-apoptotic full-length MCL1 isoform into a cell death-inducing Mcl1S isoform [4] . Thus hypoxiainduced BOK expression is not counteracted by MCL1 and its cell death promoting activities prevail, which could explain the excessive trophoblast turnover seen in pre-eclampsia.
An antisense transcript (GenBank ® accession number AL534911 with reference of GenBank ® accession numbers CR619343 and BU184197) starting from exon-2 and ending at the BOK upstream promoter region has some features of miRNA with a loop-stem region close to the transcription start site of BOK. The identification of a functional HRE in intron-1 suggests that HIF-1 may regulate transcriptions of BOK and the antisense transcript. We observed that the BOK-HRE functions in both orientations as anticipated from the BOK-HRE being a reverted repeat. The directionless feature of the BOK-HRE suggests that it can regulate the expression of the antisense transcript driven by a reverse promoter. Indeed, our data showed the existence of a functional antisense promoter in the BOK region and that the BOK-HRE serves as a hypoxia-sensitive enhancer for this promoter. Uchida et al. [41] reported that prolonged hypoxia of human lung epithelial A549 cells can induce an increase in the transcription of a natural antisense HIF-1α, whose promoter contains several putative HREs to which HIF proteins can bind. Their data suggest that HIF proteins negatively regulate HIF-1α expression through an increase in antisense HIF-1α expression, thereby causing destabilization of HIF-1α mRNA. miRNAs are thought to regulate the expression of many genes. They exert their actions at the post-transcriptional level, either via translational repression and/or mRNA degradation. Ivan and co-workers [42] have identified a number of hypoxia-regulated miRNAs which are consistently induced in response to hypoxia [43] . In addition to miRNAs that are up-regulated, another set of miRNAs have been identified that are down-regulated by hypoxia [44] [45] [46] . HIF appears to play a regulatory role for some hypoxia-induced miRNAs, including miR-210, miR-26 and miR-181 [42, 47] . A previous report showed that approximately 6 % of human miRNAs have HIF sites that are conserved across 17 species [48] , indicating the functional importance of hypoxia regulation. Given the importance of hypoxia-induced apoptosis, one set of targets worth pursuing are cell death regulators. The anti-apoptotic BCL-2 gene is an experimentally confirmed target of miR-15 and miR-16, which are down-regulated by hypoxia [44, 49] . Our BOK antisense transcript with an miRNA-like structure suggests that this antisense transcript may serve as a regulatory miRNA. The ORF of this transcript turns out to be very short, which makes it very unlikely to code for any meaningful gene product. Hence we designed experiments typically to detect miRNAs, but we were unable to identify a putative BOK miRNA. Other experiments intended to identify whether antisense-BOK functioned as a regulatory RNA were also negative. Overexpression of BOK together with antisense-BOK did not affect BOK mRNA and protein levels, suggesting no interference with the translation of BOK. Also, a splicing interfering mechanism (i.e. RNA masking) was excluded. The functions of most known antisense transcripts are unknown and elucidating the exact function of antisense-BOK may be a real challenge. For now, we conclude that hypoxiainduced expression of BOK in placenta is regulated via HIF and is not affected by its antisense transcript.
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